Pinnacle Wealth Planning Services Inc. Has $464,000 Stock Holdings in Sanofi (NASDAQ:SNY)

Pinnacle Wealth Planning Services Inc. decreased its position in shares of Sanofi (NASDAQ:SNY) by 2.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 9,543 shares of the company’s stock after selling 260 shares during the quarter. Pinnacle Wealth Planning Services Inc.’s holdings in Sanofi were worth $464,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of SNY. Salem Investment Counselors Inc. acquired a new position in shares of Sanofi in the 4th quarter valued at $27,000. Venturi Wealth Management LLC lifted its stake in shares of Sanofi by 163.5% in the 4th quarter. Venturi Wealth Management LLC now owns 535 shares of the company’s stock valued at $27,000 after purchasing an additional 332 shares during the period. Frazier Financial Advisors LLC acquired a new position in shares of Sanofi in the 4th quarter valued at $28,000. Register Financial Advisors LLC acquired a new position in shares of Sanofi in the 1st quarter valued at $29,000. Finally, Larson Financial Group LLC lifted its stake in shares of Sanofi by 480.8% in the 1st quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock valued at $29,000 after purchasing an additional 500 shares during the period. Institutional investors and hedge funds own 10.04% of the company’s stock.

Sanofi Trading Up 0.5 %

Shares of SNY stock traded up $0.26 during trading hours on Friday, reaching $50.62. The company had a trading volume of 2,087,312 shares, compared to its average volume of 2,671,888. The company has a 50 day moving average of $48.97 and a 200 day moving average of $48.68. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.27 and a quick ratio of 0.87. The firm has a market cap of $128.21 billion, a price-to-earnings ratio of 25.44, a P/E/G ratio of 1.57 and a beta of 0.59. Sanofi has a 1-year low of $42.63 and a 1-year high of $55.72.

Sanofi (NASDAQ:SNY) last released its quarterly earnings data on Thursday, April 25th. The company reported $0.96 EPS for the quarter, meeting analysts’ consensus estimates of $0.96. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. The business had revenue of $11.36 billion during the quarter, compared to analysts’ expectations of $11.75 billion. On average, equities research analysts anticipate that Sanofi will post 4.14 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.